EQL Pharma AB (publ) is an entrepreneurial pharmaceutical company that prioritizes simplicity and efficiency. They specialize in the development and marketing of generic medicines, which are sold in an open and competitive market without patent protection. EQL Pharma offers a wide range of generic products, focusing on retail and hospital segments.

In the retail segment, their products are sold through various exchange systems, primarily based on price and availability. The hospital segment includes medications that are exclusively handled by healthcare professionals, such as injectables or infusion products. Additionally, EQL Pharma actively markets branded products with unique protected trademarks.

They work collaboratively with selected partners to ensure effective promotion. With a commitment to innovation, EQL Pharma identifies areas of strong growth potential, targeting therapies and markets with minimal generic competition or specific therapeutic needs. Emphasizing high-quality and cost-effective medications, EQL Pharma operates primarily in Nordic countries but aims for expansion in various therapy areas and geographies.

Contact them at info@eqlpharma. com or visit their website for more information